Global Cell Therapy Technologies Market Size & Trends Report Segmented by Product (Media, Equipment, Software), Process (Processing, Preservation), Cell Type (T-cells, Stem Cells) End User (Pharma & Biotech Companies, CMOs) & Regional Forecast to 2030
The global cell therapy technologies market is set to witness a growth rate of 12% in the next 5 years. Rising prevalence of chronic and degenerative diseases, advancements in cell therapy manufacturing technologies, supportive government and regulatory initiatives, growing investments by biotech and pharma companies, rising adoption of personalized medicine, are some of the key factors driving the cell therapy technologies market. To learn more about the research report, download a sample report.
Cell therapy technologies encompass the tools, equipment, and processes used to develop, manufacture, and deliver cell-based therapies for treating various diseases and medical conditions. These technologies support the isolation, modification, expansion, and administration of live cells, such as stem cells, T-cells, or dendritic cells, for therapeutic purposes. They include bioreactors, cell culture systems, flow cytometers, cell preservation tools, and automation platforms. Designed to ensure consistency, sterility, scalability, and regulatory compliance, these technologies are essential for both autologous (patient-derived) and allogeneic (donor-derived) therapies. Their rapid evolution is enabling advancements in regenerative medicine, immunotherapy, and personalized treatment strategies.
To learn more about this report, download the PDF brochure
Advancements in cell therapy manufacturing technologies to drive market growth
Advancements in cell therapy manufacturing technologies are significantly driving the growth of the cell therapy technologies market by improving scalability, efficiency, and consistency in production. Innovations such as closed system bioreactors, automated cell culture platforms, and 3D culture systems minimize contamination risks and reduce manual labor, enabling cost-effective and reproducible manufacturing processes. These technologies also support high-throughput and real-time monitoring, which are critical for meeting regulatory standards and ensuring product quality. As demand for personalized and allogeneic therapies grows, advanced manufacturing solutions are crucial for transitioning from small-scale research to large-scale commercial production, accelerating market expansion and clinical adoption.
Shift toward allogeneic cell therapies: A key market trend
A key trend driving the cell therapy technologies market is the shift toward allogeneic cell therapies, which use donor-derived cells that can be manufactured in bulk and stored for off-the-shelf use. Unlike autologous therapies, which are personalized and time-consuming, allogeneic therapies offer greater scalability, faster treatment timelines, and lower production costs. This trend is accelerating due to advancements in immune-matching techniques and gene editing, which reduce the risk of rejection. As demand for broader patient access and commercial viability grows, the development of universal donor cell lines is becoming a central focus for biopharma and technology providers alike.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global cell therapy technologies market is marked by the presence of established and emerging market players such as Thermo Fisher Scientific Inc., Sartorius AG, Lonza, DH Life Sciences, LLC, Merck KGaA, Agilent Technologies, Inc., Avantor, Inc., Fresenius SE & Co. KGaA, BD, MaxCyte; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 - 2024 |
| Forecast Period | 2025 - 2030 |
| Growth Rate | 12% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Process, Cell Type, End User |
| Regional Scope |
|
| Key Companies Mapped | Thermo Fisher Scientific Inc., Sartorius AG, Lonza, DH Life Sciences, LLC, Merck KGaA, Agilent Technologies, Inc., Avantor, Inc., Fresenius SE & Co. KGaA, BD, MaxCyte among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Cell Therapy Technologies Market Segmentation
This report by Medi-Tech Insights provides the size of the global cell therapy technologies market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, process, cell type, end user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Media, Reagents, and Sera
- Cell Therapy Equipment
- Systems & Software
- Cell Culture Vessels
- Cell Engineering Products
- Others
Market Size & Forecast (2023-2030), By Process, USD Million
- Cell Processing
- Cell Preservation
- Process Monitoring and Quality Control
- Cell Handling
- Cell Distribution
Market Size & Forecast (2023-2030), By Cell Type, USD Million
- T-cells
- Stem Cells
- Others
Market Size & Forecast (2023-2030), By End User, USD Million
- Research Institutes and Academic Centers
- Biotechnology and Pharmaceutical Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the cell therapy technologies market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the cell therapy technologies market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Cell Therapy Technologies Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising prevalence of chronic and degenerative diseases
- Advancements in cell therapy manufacturing technologies
- Supportive government and regulatory initiatives
- Growing investments by biotech and pharma companies
- Rising adoption of personalized medicine
- Restraints
- High cost of cell therapy and related technologies
- Complex manufacturing and quality control requirements
- Ethical and regulatory concerns
- Limited reimbursement policies
- Opportunities
- Emerging applications beyond oncology
- Increasing collaborations and strategic partnerships
- Development of off-the-shelf (allogeneic) cell therapies
- Growth of emerging markets
- Key Market Trends
- Rise of integrated and closed-system technologies
- Advancements in cryopreservation and cold chain logistics
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Cell Therapy Technologies Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Media, Reagents, and Sera
- Cell Therapy Equipment
- Systems & Software
- Cell Culture Vessels
- Cell Engineering Products
- Others
- Global Cell Therapy Technologies Market Size & Forecast (2023-2030), By Process, USD Million
- Introduction
- Cell Processing
- Cell Preservation
- Process Monitoring and Quality Control
- Cell Handling
- Cell Distribution
- Global Cell Therapy Technologies Market Size & Forecast (2023-2030), By Cell Type, USD Million
- Introduction
- T-cells
- Stem Cells
- Others
- Global Cell Therapy Technologies Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Research Institutes and Academic Centers
- Biotechnology and Pharmaceutical Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Others
- Global Cell Therapy Technologies Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Cell Therapy Technologies Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Cell Therapy Technologies Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Cell Therapy Technologies Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Cell Therapy Technologies Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Cell Therapy Technologies Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Process (USD Million)
- Market Size & Forecast, By Cell Type (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Lonza
- DH Life Sciences, LLC
- Merck KGaA
- Agilent Technologies, Inc.
- Avantor, Inc.
- Fresenius SE & Co. KGaA
- BD
- MaxCyte
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Research Institutes and Academic Centers; Biotechnology and Pharmaceutical Companies; Contract Development and Manufacturing Organizations (CDMOs); and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
